» Articles » PMID: 35810412

Referring Patients with Suspected Lung Cancer: a Qualitative Study with Primary Healthcare Professionals in Ireland

Abstract

Lung cancer is the leading cause of cancer death globally. Most cases are diagnosed late. Primary healthcare professionals are often the first point of contact for symptoms of concern. This study explored primary healthcare professionals' experience of referring individuals with signs and symptoms suggestive of lung cancer along the appropriate healthcare pathway and explored strategies to help primary healthcare professionals detect lung cancer early. Focus groups and individual interviews were conducted with 36 general practitioners, community pharmacists, practice nurses, and public health nurses. Data were analysed thematically. Participants identified typical lung cancer signs and symptoms such as cough and coughing up blood (i.e., haemoptysis) as triggers for referral. Atypical/non-specific signs and symptoms such as back pain, pallor, and abnormal blood tests were perceived as difficult to interpret. Participants often refrained from using the word 'cancer' during conversations with patients. Ireland's Rapid Access Lung Clinics were perceived as underused, with some general practitioners referring patients to these clinics only when clear and definitive lung cancer signs and symptoms are noted. Lack of communication and the resulting disruption in continuity of care for patients with suspected lung cancer were highlighted as healthcare system flaws. Education on early referral can be in the form of communications from professional organizations, webinars, interdisciplinary meetings, education by lung specialists, and patient testimonials. Lung cancer referral checklists and algorithms should be simple, clear, and visually appealing, either developed as standalone tools or embedded into existing primary care software/programmes.

Citing Articles

Impact of the COVID-19 pandemic on electronic referrals to rapid access clinics for suspected breast, lung and prostate cancers in Ireland.

Bambury N, Zhang M, McCarthy T, Dawkins I, Burke L, Tierney P Eur J Public Health. 2024; 34(5):908-913.

PMID: 39160755 PMC: 11430919. DOI: 10.1093/eurpub/ckae092.


The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach.

Tsiligianni I, Christodoulakis A, Monastirioti A, Mavroudis D, Agelaki S NPJ Prim Care Respir Med. 2024; 34(1):5.

PMID: 38684681 PMC: 11058196. DOI: 10.1038/s41533-024-00359-w.


A systematic review of interventions to recognise, refer and diagnose patients with lung cancer symptoms.

Saab M, McCarthy M, ODriscoll M, Sahm L, Leahy-Warren P, Noonan B NPJ Prim Care Respir Med. 2022; 32(1):42.

PMID: 36258020 PMC: 9579201. DOI: 10.1038/s41533-022-00312-9.

References
1.
Cunningham Y, Wyke S, Blyth K, Rigg D, Macdonald S, Macleod U . Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: A qualitative interview study. Psychooncology. 2019; 28(4):718-725. PMC: 6492269. DOI: 10.1002/pon.5005. View

2.
Paul I, Levi B . Metastasis of e-mail at an academic medical center. JAMA Pediatr. 2014; 168(3):290-1. DOI: 10.1001/jamapediatrics.2013.3934. View

3.
Sandelowski M . Whatever happened to qualitative description?. Res Nurs Health. 2000; 23(4):334-40. DOI: 10.1002/1098-240x(200008)23:4<334::aid-nur9>3.0.co;2-g. View

4.
Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A . Quality of life of patients with lung cancer. Onco Targets Ther. 2016; 9:1023-8. PMC: 4778772. DOI: 10.2147/OTT.S100685. View

5.
Lambert S, Loiselle C . Combining individual interviews and focus groups to enhance data richness. J Adv Nurs. 2008; 62(2):228-37. DOI: 10.1111/j.1365-2648.2007.04559.x. View